Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses.
about
Health-related quality of life in hypertension, chronic kidney disease, and coexistent chronic health conditions.Reciprocal regulation between proinflammatory cytokine-induced inducible NO synthase (iNOS) and connexin43 in bladder smooth muscle cellsInhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseTherapeutic effects of human amniotic fluid-derived stem cells on renal interstitial fibrosis in a murine model of unilateral ureteral obstructionSafety of ACE inhibitor therapies in patients with chronic kidney disease.Hypokalemia, its contributing factors and renal outcomes in patients with chronic kidney disease.The effectiveness of long-term agalsidase alfa therapy in the treatment of Fabry nephropathy.Retarding the progression of chronic kidney disease with renin angiotensin system blockadeAMPK Suppresses Connexin43 Expression in the Bladder and Ameliorates Voiding Dysfunction in Cyclophosphamide-induced Mouse Cystitis.Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension.Mechanisms of disease: Fibroblasts--a new look at an old problem.Oral direct renin inhibition: premise, promise, and potential limitations of a new antihypertensive drug.Embryonic Stem Cells-loaded Gelatin Microcryogels Slow Progression of Chronic Kidney DiseaseObesity, Renin-Angiotensin System Blockade and Risk of Adverse Renal Outcomes: A Population-Based Cohort StudyGap junctional intercellular communication in the juxtaglomerular apparatus.Adjuvant treatments for Henoch-Schönlein purpura nephritis in children: A systematic reviewManagement of idiopathic membranous nephropathy.Direct inhibition of plasmatic renin activity with aliskiren: a promising but under-investigated therapeutic option for non-diabetic glomerulonephritis.Adiponectin attenuates Ang Ⅱ-induced TGFβ1 production in human mesangial cells via an AMPK-dependent pathway.THE IMPACT OF CARDIOVASCULAR DRUGS ON GLYCEMIC CONTROL: A REVIEW.TDAG51 mediates epithelial-to-mesenchymal transition in human proximal tubular epithelium.Medium-term follow-up of renal function in hypoxaemic congenital heart disease patients.Endogenous and exogenous NO attenuates conduction of vasoconstrictions along arterioles in the microcirculation.Myocardial infarction does not further impair renal damage in 5/6 nephrectomized rats.Assessment of a lupus nephritis cohort over a 30-year period.Bone Marrow-Derived Mesenchymal Stem Cells and Their Conditioned Medium Attenuate Fibrosis in an Irreversible Model of Unilateral Ureteral Obstruction.Synergistic effects of PDGF-BB and cAMP-elevating agents on expression of connexin43 in mesangial cells.Chronic kidney disease in primary care.
P2860
Q27687254-11AB14EC-19BB-4F59-BA26-E1B6D14EC661Q28569184-EA20DAA8-1869-4D43-AC88-D73A1D9D23BDQ33652488-304919EC-A8CD-4C35-A5A6-B231F845C668Q34347818-24742459-1D32-408B-B327-9DDBC728D3F8Q34434606-7576FAAB-DFC7-4D95-809D-6804C1CA8D9EQ34812460-2C5B5648-49FD-4F61-80B8-9732AD49C1B7Q35692435-784D0574-FCC7-4287-BD06-270872262800Q36082302-D9C6B73D-F125-4D05-B970-0F1E9B61FDA2Q36500671-717BCB49-021E-4C58-B6CD-F855D09DEC40Q36562461-8B01542C-5BE8-4BDA-A4F6-A56333C33042Q36577128-5E0820F6-3AFD-49E1-B0AF-973446115F52Q36688756-6FDDFB6D-F96C-4D96-8094-8906BAE71D70Q36709351-D2A79913-CF67-442C-9188-17392BF0A3FCQ37114337-EAC872CB-1544-4A1E-B994-1D0EAC62FB80Q37346546-D4B18CEE-5EDD-4C84-811A-2781CE173F7FQ37667314-2D651AA2-7BBB-42DD-BACF-19EA80CDDA7EQ37779802-829CD779-D922-4B48-B477-F185F7ABAFACQ38599694-8DB29C28-DC65-4F10-8D63-9225C39D12FFQ38932521-B5E0D3D9-4AA5-40A6-AC86-1A270CDF7BB9Q39038196-01356508-5D51-4151-9EDD-59D1EAA81706Q39347231-F138F5BB-038E-446B-8992-729137ABB541Q40528090-E7D48AA8-541C-4D33-9E9E-0CDC962C840BQ42506747-03C3F587-2001-473F-8D8B-6FD5A05CB1BCQ46575615-AC5CB4B2-5A0E-4765-B566-1A7C1E680F41Q51048045-F9B0212A-7093-43C4-91A0-F94C09D0A563Q51053705-FFF63526-AC4C-439D-B6C9-FF3044D36CF7Q51326823-6145D5BE-5ED8-4E79-952E-174CFD7E8C53Q55716533-2C39FCB8-848E-41D9-B19A-E8D6169B33C0
P2860
Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@ast
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@en
type
label
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@ast
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@en
prefLabel
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@ast
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@en
P356
P1476
Angiotensin-converting enzyme ...... the data of the meta-analyses.
@en
P2093
Carlos Chiurchiu
P304
P356
10.1681/ASN.2004110968
P478
16 Suppl 1
P577
2005-03-01T00:00:00Z